Skip to main content

MoneyWorks4Me

Indoco Remedies informs about press release

06 Aug 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Indoco Remedies has informed that it has enclosed a Press Release as on 6th August 2020 titled ‘Indoco receives USFDA approval for Olanzapine Tablets’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1794.30
Dr. Reddys Labs. 1353.10
Cipla 1369.05
Lupin 1988.00
Zydus Lifesciences 1201.20
View more..